Omega Healthcare Investors, Inc. (NYSE:OHI) Shares Sold by Stifel Financial Corp

Stifel Financial Corp cut its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 8.7% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 302,641 shares of the real estate investment trust's stock after selling 28,801 shares during the period. Stifel Financial Corp owned approximately 0.11% of Omega Healthcare Investors worth $12,318,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Allworth Financial LP boosted its holdings in shares of Omega Healthcare Investors by 12.0% in the third quarter. Allworth Financial LP now owns 2,276 shares of the real estate investment trust's stock valued at $93,000 after acquiring an additional 244 shares in the last quarter. Venturi Wealth Management LLC raised its stake in shares of Omega Healthcare Investors by 29.4% during the 3rd quarter. Venturi Wealth Management LLC now owns 1,259 shares of the real estate investment trust's stock worth $51,000 after buying an additional 286 shares in the last quarter. Cutter & CO Brokerage Inc. lifted its holdings in shares of Omega Healthcare Investors by 3.7% in the 2nd quarter. Cutter & CO Brokerage Inc. now owns 8,206 shares of the real estate investment trust's stock valued at $281,000 after buying an additional 290 shares during the period. NCP Inc. boosted its stake in shares of Omega Healthcare Investors by 10.3% in the second quarter. NCP Inc. now owns 3,310 shares of the real estate investment trust's stock valued at $113,000 after buying an additional 310 shares in the last quarter. Finally, V Square Quantitative Management LLC grew its holdings in Omega Healthcare Investors by 49.5% during the third quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust's stock worth $40,000 after acquiring an additional 323 shares during the period. 65.25% of the stock is owned by institutional investors and hedge funds.

Omega Healthcare Investors Price Performance

Shares of NYSE:OHI traded down $0.08 on Thursday, hitting $38.77. The company had a trading volume of 1,669,227 shares, compared to its average volume of 1,688,117. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. The company has a market cap of $10.47 billion, a PE ratio of 28.53, a PEG ratio of 1.22 and a beta of 0.98. Omega Healthcare Investors, Inc. has a 52-week low of $27.53 and a 52-week high of $44.42. The business has a 50 day moving average of $40.41 and a 200 day moving average of $37.81.

Omega Healthcare Investors Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were paid a dividend of $0.67 per share. The ex-dividend date was Monday, November 4th. This represents a $2.68 annualized dividend and a dividend yield of 6.91%. Omega Healthcare Investors's dividend payout ratio is currently 197.06%.

Insiders Place Their Bets

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares of the company's stock, valued at $4,025,000. This represents a 36.19 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares of the company's stock, valued at approximately $7,357,824.44. This represents a 10.96 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Wells Fargo & Company restated an "overweight" rating and set a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Truist Financial upped their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "hold" rating in a research report on Wednesday, September 4th. Royal Bank of Canada boosted their price target on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a "sector perform" rating in a research note on Monday, November 11th. BMO Capital Markets upgraded Omega Healthcare Investors from a "market perform" rating to an "outperform" rating and set a $45.00 price target on the stock in a report on Monday. Finally, BNP Paribas raised Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 price objective for the company in a report on Thursday, October 31st. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $40.18.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.